Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-469

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-469-30 (Label 30crc)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by Proficient Rx LP. The label states 30 capsules per bottle. Capsules are described as size '2' hard gelatin, olive green cap and light yellow body, with '160' imprinted in black ink. Manufacturer listed as Sun Pharmaceutical Ind. Ltd., Gujarat, India.*

FDA Label Image

Figure-1 (Tamsulosin Fig1)

A line chart depicting the plasma concentration of Tamsulosin Hydrochloride (ng/mL) over time (hours) for fasted and fed states. The graph shows concentration levels peaking earlier and higher in the fasted state compared to the fed state, with both declining gradually over 36 hours.*

FDA Label Image

Figure-2a (Tamsulosin Fig2a)

A line graph showing the mean change over time in a treatment study of Tamsulosin Hydrochloride capsules, 0.4 mg and 0.8 mg doses, compared to placebo. The x-axis represents the duration of treatment in weeks, and the y-axis shows mean change. Three lines represent 0.8 mg dose, 0.4 mg dose, and placebo, with sample sizes noted below the timeline. Both Tamsulosin doses show a greater mean change than placebo during the treatment period up to 13 weeks.*

FDA Label Image

Figure-2b (Tamsulosin Fig2b)

A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The mean change decreases over time for both doses, with the placebo showing less change. The x-axis represents treatment duration in weeks, and the y-axis represents mean change values, trending downward.*

FDA Label Image

Tamsulosin-fig3a (Tamsulosin Fig3a)

A line graph showing mean change over duration of treatment in weeks for three treatment groups: 0.8 mg, 0.4 mg, and placebo. The vertical axis represents mean change in mL/sec, ranging from 0 to 3. The horizontal axis shows treatment duration from baseline to 13 weeks and LCOF. Data points are plotted with different symbols for each treatment group, indicating comparative trends over time.*

FDA Label Image

Tamsulosin-fig3b (Tamsulosin Fig3b)

A line graph depicting mean change in mL/sec over treatment duration in weeks for Tamsulosin Hydrochloride at two doses (0.8 mg and 0.4 mg) compared to placebo. The graph shows data points at multiple time intervals with sample sizes noted, illustrating treatment efficacy over time.*

FDA Label Image

Chemical-structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular configuration including aromatic rings, methoxy groups, and hydrochloride salt form as indicated by the accompanying HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.